Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia by Levy CIMAR | Jan 6, 2026 | Publications
An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against Acinetobacter baumannii Infection by Levy CIMAR | Feb 25, 2025 | Publications